Centogene NV

NASDAQ: CNTG
Share price (5/16/24): $0.38
Market cap (5/16/24): $10.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

4 Centogene NV Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/31/23 FY 2023

Late filing notification for annual report of foreign issuer

ended 12/31/22 FY 2022

Late filing notification for annual report of foreign issuer

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers

Correspondence regarding draft registration statement

Draft registration statement

Prospectus supplement with pricing info

Ownership Filter

TVM Life Science Innovation I L.P.

DPE Deutsche Private Equity Gesellschaft mbH

Platinum Investment Management Ltd

Stoffelen Richard

Stoffelen Richard

News Filter

Reports Full Year 2023 Financial Results and Recent Business Highlights

DATED April 23, 2024

CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients

1. Lifera Loan Amendment

Proxies

No filings in this category.

Other Filter

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Notice of effectiveness

Correspondence with the SEC